TheStreet.com

I Markets I
Palm: Analysts' Upgrades, Downgrades
By TSC Staff

11/05/09 09:07 AM EST

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Palm (PALM:NYSE) upgraded at Barclays to Equal Weight from Underweight on limited downside. Price target cut to $11 from $12. 2010 and 2011 EPS estimates set at -$0.26 and $0.29, respectively.

Molson Coors (TAP:NYSE) downgraded at Goldman from Buy to Neutral. Despite low valuation, see limited upside potential, as volume trends are weak. $53 price target.

Terex (TEX:NYSE) downgraded at Morgan Stanley from Equal-weight to Underweight. $18 price target. Company faces more headwinds than its peers, and will likely be later to recover.

STOCK COMMENTS / EPS CHANGES

Automatic Data (ADP:NYSE) estimates increased at Goldman through 2012. Company is realizing higher operating margins. Neutral rating and $43 price target.

Agrium (AGU:NYSE) estimates, target cut at UBS. Shares of AGU now seen reaching $50. Estimates also lowered, to reflect a late planting season and lower price expectations. Neutral rating.

Allstate (ALL:NYSE) estimates boosted at UBS through 2010. Sales have stabilized, and auto profitability is rising. Neutral rating and $31.50 price target.

Applied Materials (AMAT:NYSE) estimates boosted at UBS through 2010. Company likely seeing higher silicon orders from Taiwan. Buy rating and $17 price target.

Alpha Natural (ANR:NYSE) numbers boosted at FBR. Shares of ANR now seen reaching $54. Estimates also raised, to reflect higher met coal volumes. Outperform rating.

Baker Hughes (BHI:NYSE) estimates lowered at Goldman through 2011. Company is seeing lower international margins.

Bucyrus (BUCY:NYSE) estimates raised at Goldman through 2011. Visibility is improving for new equipment production. Buy rating and $62 price target.

Career Education (CECO:NYSE) estimates boosted at UBS through 2010. Company is seeing higher revenue per enrollment. Buy rating and $30 price target.

Commercial Metals (CMC:NYSE) numbers lowered at Goldman through 2011. Mill margins are eroding and trading profits remain under pressure. Neutral rating and new $16 price target.

Comcast (CMCSA:NYSE) estimates raised at Goldman through 2011. Company is seeing better subscriber growth. Buy rating and $18 price target.

Charles River Labs (CRL:NYSE) numbers cut at Goldman through 2012. Pre-clinical demand remains weak. Neutral rating and new $35 price target.

Cisco Systems (CSCO:NYSE) numbers raised at Goldman. Shares of CSCO now seen reaching $26. Estimates also boosted, to reflect a recovery in enterprise spending. Neutral rating.

Amdocs (DOX:NYSE) estimates, target boosted at Goldman. Shares of DOX now seen reaching $28. Estimates also raised, to reflect higher realized margins. Neutral rating.

Devon Energy (DVN:NYSE) price target, estimates raised at Barclays. Barclays increased DVN price target to $78 from $64 on higher 4Q volume guidance. 2009 and 2010 EPS estimates raised to $3.55 and $6.15, respectively. Maintain Equal Weight rating.

Devon (DVN:NYSE) estimates raised at Goldman through 2011. Company is seeing higher production rates and lower realized costs. Buy rating and $90 price target.

Fortune Brands (FO:NYSE) initiated at BofA/Merrill with a Neutral rating and $43 price target. Slow recovery in home and consumer spending. 2009 and 2010 EPS estimates set at $2.28 and $2.79, respectively.

Foster Wheeler (FWLT:NYSE) price target, estimates higher at Barclays. Raised FWLT price target to $41 from $37 on solid 3Q results. Maintain Overweight rating. 2009 and 2010 EPS estimates lifted to $2.99 and $2.55.

Garmin (GRMN:NYSE) estimates boosted at Goldman through 2011. Company is seeing higher margins, but smartphones are starting to cannibalize the business. Sell rating and $26 price target.

Microchip (MCHP:NYSE) estimates, target boosted at Goldman. Shares of MCHP now seen reaching $22. Estimates also raised, to reflect a higher sales outlook and cost cutting. Sell rating.

Mercadolibre (MELI:NYSE) estimates boosted at Morgan Stanley through 2011. Company is realizing higher sales growth. Equal-weight rating.

News Corp. (NWSA:NYSE) estimates raised at UBS through 2011. Broadcast and cable ad trends are improving. Neutral rating and $12 price target.

News Corp. (NWSA:NYSE) price target, estimates raised at Barclays. NWSA price target increased to $14 from $12. 2010 EPS estimate lifted by 3 cents to $0.81, 2011 introduced at $1.05. Maintain Equal Weight rating.

Oil States Int'l. (OIS:NYSE) numbers boosted at Goldman. Shares of OIS now seen reaching $41. Estimates also raised, as the company is seeing better offshore and tubular margins. Neutral rating.

ON Semiconductor (ONNN:NYSE) estimates increased at UBS through 2010. Company is seeing higher margins and using cash flow to pay down debt. Buy rating and $12 price target.

Qualcomm (QCOM:NYSE) estimates, target lowered at FBR. Shares of QCOM now seen reaching $48. Estimates also reduced, to match the company's new guidance. Outperform rating.

Transocean (RIG:NYSE) estimates lowered at Goldman through 2011. Company is facing higher interest expenses, but still has attractive deepwater assets. Buy rating and $111 price target.

Tyco Electronics (TEL:NYSE) numbers increased at UBS. Shares of TEL now seen reaching $27. Estimates also boosted, to reflect higher realized operating margins. Buy rating.

Tenet Healthcare (THC:NYSE) estimates increased at UBS through 2010. Company raised sales guidance and is keeping a tight lid on costs. Neutral rating and $6 price target.

TRW Automotive (TRW:NYSE) numbers boosted at Goldman. Shares of TRW now seen reaching $24. Estimates also increased, to reflect higher realized sales and margins. Neutral rating.

Time Warner (TWX:NYSE) price target, estimates higher at Barclays. TWX price target inflated by a dollar to $31. 2009 and 2010 EPS estimates raised to $2.09 and $2.25, respectively. Maintain Equal Weight rating.

Time Warner (TWX:NYSE) estimates boosted at Goldman through 2010. Company is seeing better content results. Buy rating and $36 price target.

Varian (VARI:NYSE) estimates lowered at UBS through 2010. Company is seeing lower sales of scientific instruments and has limited forward visibility. Neutral rating and $52 price target.

Wellcare (WCG:NYSE) estimates lowered at Goldman through 2011. Company seeing lower enrollment rates. Buy rating and $34 price target.

Whole Foods (WFMI:NYSE) estimates raised at Morgan Stanley through 2012. Company is realizing better margins across the board. Equal-weight rating.

XTO (XTO:NYSE) price target, estimates boosted at Barclays. XTO price target surged to $57 from $47 on strong growth prospects. 2009 and 2010 EPS estimates each raised by 5 cents to $3.55 and $1.70, respectively. Reiterate Overweight rating.

Try a 30-day FREE trial to RealMoney.com!